key: cord-0821975-xojkpnmo
authors: Hughes, Stephen; Troise, Oliver; Donaldson, Hugo; Mughal, Nabeela; Moore, Luke SP.
title: Bacterial and fungal coinfection among hospitalised patients with COVID-19: A retrospective cohort study in a UK secondary care setting
date: 2020-06-27
journal: Clin Microbiol Infect
DOI: 10.1016/j.cmi.2020.06.025
sha: 5fab70c076c10c316a3d7cba4184ee81bcae756f
doc_id: 821975
cord_uid: xojkpnmo

OBJECTIVES: We investigate the incidence of bacterial and fungal co-infection of hospitalised patients with confirmed SARS-CoV-2 in this retrospective observational study across two London hospitals during the first UK wave of COVID-19. METHODS: A retrospective case-series of hospitalised patients with confirmed SARS-CoV-2 by PCR was analysed across two acute NHS hospitals (February 20–April 20; each isolate reviewed independently in parallel). This was contrasted to a control group of influenza positive patients admitted during 2019/20 flu season. Patient demographics, microbiology, and clinical outcomes were analysed. RESULTS: 836 patients with confirmed SARS-CoV-2 were included; 27/836(3.2%) had early confirmed bacterial isolates identified (0-5 days post-admission) rising to 51/836(6.1%) throughout admission. Blood cultures, respiratory samples, pneumococcal or legionella urinary antigens, and respiratory viral PCR panels were obtained from 643(77%), 112(13%), 249(30%), 246(29%) and 250(30%) COVID-19 patients, respectively. A positive blood culture was identified in 60(7.1%) patients, of which 39/60 were classified as contaminants. Bacteraemia secondary to respiratory infection was confirmed in two cases (1 community-acquired K. pneumoniae and 1 ventilator-associated E. cloacae). Line-related bacteraemia was identified in six patients (3 candida, 2 Enterococcus spp. and 1 Pseudomonas aeruginosa). All other community acquired bacteraemias(16) were attributed to non-respiratory infection. Zero concomitant pneumococcal, legionella or influenza infection was detected. A low yield of positive respiratory cultures was identified; S. aureus the most common respiratory pathogen isolated in community-acquired coinfection (4/24;16.7%) with pseudomonas and yeast identified in late-onset infection. Invasive fungal infections (n=3) were attributed to line related infections. Comparable rates of positive co-infection were identified in the control group of confirmed influenza infection; clinically relevant bacteraemias (2/141;1.4%), respiratory cultures (10/38;26.1%) and pneumococcal-positive antigens (1/19;5.2%) were low. CONCLUSION: We find a low frequency of bacterial co-infection in early COVID hospital presentation, and no evidence of concomitant fungal infection, at least in the early phase of COVID-19.

and respiratory viral PCR panels were obtained from 643(77%), 112(13%), 249(30%), 48 246(29%) and 250(30%) COVID-19 patients, respectively. A positive blood culture was 49 identified in 60(7.1%) patients, of which 39/60 were classified as contaminants. Bacteraemia 50 secondary to respiratory infection was confirmed in two cases (1 community-acquired K. 51 pneumoniae and 1 ventilator-associated E. cloacae). Line-related bacteraemia was identified 52 in six patients (3 candida, 2 Enterococcus spp. and 1 Pseudomonas aeruginosa). All other 53 community acquired bacteraemias(16) were attributed to non-respiratory infection. Zero Relevant to the COVID-19 NICE guidance, and the doxycycline and amoxicillin advocated, 84 there is an urgent need to characterise the frequency, nature and the UK. To investigate this, 85 we undertook a retrospective observational analysis of patients admitted with confirmed 86 SARS-CoV-2. A control group of patients with confirmed influenza was used as a comparator 87 to derive relative rates of secondary infections between these two viral pneumonitis 88 presentations and explore any variation in causative organisms. Table 1 ]. There 159 was high sampling rate for blood culture in both the SARS-CoV-2 cohort (643/836) and among frequency of respiratory (sputum or bronchiolar lavage) sample culture (Table 1 ). The SARS-162 CoV-2 group had significantly (p<0.0001) higher frequency of samples sent for pneumococcal 163 and legionella urinary antigens (Table 1 ). In total, 27/836(3.2%) had early confirmed bacterial 164 isolates identified (0-5days post admission) rising to 51/836 (6.1%) throughout admission. There was no significant difference in sampling rates (73% vs 80%) or positivity rates (7.5% vs pneumoniae. The total number of pathogens exceeds the total number of blood cultures as more than 13 one isolate can be identified in a single culture.

COVID-19: infection prevention and control (IPC) -GOV

Rates of Co-infection Between SARS-CoV-2 and Other 386 Respiratory Pathogens

Invasive aspergillosis in patients 389 admitted to the intensive care unit with severe influenza: a retrospective cohort study